Wednesday
SESSION 31: ADVANCES IN MEDICAL TREATMENTS, NEW ANTIATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
Moderators:Ido Weinberg, MD, MSc / Bhama Ramkhelawon, PhD  
SESSION 31 SCHEDULE
3:56 PM - 4:01 PM What Adequate And Ideal Lipid Levels Should We Strive For In PAD Patients: How To Get There
  Presenter(s):Marianne Brodmann, MD  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
4:02 PM - 4:07 PM Risks And Consequences Of Perioperative Myocardial Infarctions (MIs) In Open Vascular Surgery Patients: What Can Be Done To Decrease MI Incidence And Their Morbidity And Mortality When They Occur
  Presenter(s):Peter Henke, MD  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
4:08 PM - 4:13 PM

Power Point Presentation with Synched Audio
Update On LDL-C Lowering During A Lifetime: How Low To Strive For; How Young To Start If High; How Old To Continue Statins
  Presenter(s):J. David Spence, MD  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
4:14 PM - 4:19 PM DEBATE: LDL-C Lowering And Statins For Prophylaxis Of Vascular Events Are Dangerous And Not Helpful
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
4:20 PM - 4:25 PM DEBATE: Not So: LDL-C Lowering With Statins And Other Drugs Stabilizes And Shrinks Plaques And Decreases Morbid Vascular Events: Stopping Statins Increases Patientsí Risk Of MI And Death
  Presenter(s):Ron Waksman, MD  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
4:26 PM - 4:31 PM Low Dose Rivaroxaban And Aspirin Improve Survival And Decrease Major Adverse Limb Events (MALE) After Endo And Open Treatments For PAD/CLTI: From The VOYAGER RCT
  Presenter(s):Sebastian E. Debus, MD, PhD / Marianne Brodmann, MD  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
4:32 PM - 4:37 PM How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And COMPASS Trials
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
4:38 PM - 4:43 PM New Adjunctive Drugs (Plus Statins) To Lower LDL-Cholesterol (LDL-C) In Vascular Patients: Inclisiran, Bempedoic Acid And Ezetimbe: How Do They Work And When And How To Use Them: Level Of LDL-C To Strive For
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
4:44 PM - 4:50 PM Panel Discussion
END OF SESSION 31
previous next